Cellergy Therapeutics
Recharging Life by Restoring Cellular Energy
StartupCellergy Therapeutics is a Yavne-based startup in the Health Tech & Life Sciences sector, established in 2021. Recharging Life by Restoring Cellular Energy. The company has 1-10 employees. Core technologies: Biologicals, Cells.
The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQYavne
- DistrictCenter District
- Last RoundUndisclosed
1 article covered by sources including www.haaretz.com.
What does Cellergy Therapeutics do?
Cellergy is producing a large quantity of mitochondrial product from human primary sources for systemic, repeated administration, using fully matched allogeneic purified mitochondria delivered via IV for major systemic indications such as CNS disorders, muscle degeneration, and aging. Its breakthrough approach harnesses the power of young, healthy mitochondria to revolutionize the treatment of degenerative and metabolic diseases. Through innovative mitochondrial transplantation therapy, Cellergy replaces compromised mitochondria with fully functional ones, effectively restoring cellular energy production and enhancing cell function. The company is transforming human health by providing the power of young and healthy mitochondria to energize cells, fight degenerative diseases and enhance healthy longevity.
What sector is Cellergy Therapeutics in?
Cellergy Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.
Where is Cellergy Therapeutics located?
Cellergy Therapeutics is based in Yavne, Israel, Center District.